Actuate Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -2.52%
- Market cap
- $7.38M
- 24.75M shares
- Filings
- 193
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026+52.3% FY25 yoy
- $7.38M
- —
- —
- —
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $10,292,620 | reported | |
| FY 2024 | 2024-12-31 | $18,676,276 | reported | |
| FY 2023 | 2023-12-31 | $21,708,332 | reported |
Pharmaceutical preparations
Actuate Therapeutics, Inc. is the 439th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ENSCEnsysce Biosciences, Inc.$5.1M2.8%200.8%$7.6MSNGXSoligenix, Inc.———$7.5MLTRNLantern Pharma Inc.———$7.4MTOVXTheriva Biologics, Inc.———$7.4MIMRNImmuron LtdFiscal 2022 figures———$7.2M
ACTUActuate Therapeutics, Inc. (this company)———$7.2M
CNSPCNS Pharmaceuticals, Inc.———$7.1MPBMPsyence Biomedical Ltd.Fiscal 2025 figures———$7.1MRVPHReviva Pharmaceuticals Holdings, Inc.———$6.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Actuate Therapeutics, Inc. · CIK 1652935 · Engraved from SEC EDGAR